These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33507673)

  • 1. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
    Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects.
    Ma Y; Yang J; Zhang P; Liu Z; Yang Z; Qin H
    Breast Cancer Res Treat; 2011 Jan; 125(1):237-41. PubMed ID: 20524057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies.
    Lu S; Wang Z; Liu H; Hao X
    Breast Cancer Res Treat; 2010 Dec; 124(3):771-8. PubMed ID: 20401632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Her2
    Krishna BM; Chaudhary S; Panda AK; Mishra DR; Mishra SK
    Sci Rep; 2018 May; 8(1):7427. PubMed ID: 29743533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
    J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies.
    Chen W; Yang H; Tang WR; Feng SJ; Wei YL
    Asian Pac J Cancer Prev; 2014; 15(22):9643-7. PubMed ID: 25520082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of the HER2 Ile655Val polymorphism in relation to risk of invasive breast cancer.
    Nelson SE; Gould MN; Hampton JM; Trentham-Dietz A
    Breast Cancer Res; 2005; 7(3):R357-64. PubMed ID: 15987431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epithelial growth factor receptor 2[Ile655Val] polymorphism and risk of breast fibroadenoma.
    Zubor P; Kajo K; Stanclova A; Szunyogh N; Galo S; Dussan CA; Minarik G; Visnovsky J; Danko J
    Eur J Cancer Prev; 2008 Feb; 17(1):33-8. PubMed ID: 18090908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione S-transferase P1 Ile105Val polymorphism and breast cancer risk: a meta-analysis involving 34,658 subjects.
    Lu S; Wang Z; Cui D; Liu H; Hao X
    Breast Cancer Res Treat; 2011 Jan; 125(1):253-9. PubMed ID: 20526737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.
    Riaz SK; Rashid MM; Kayani MA; Arshad Malik MF
    Arch Iran Med; 2016 Jun; 19(6):430-8. PubMed ID: 27293060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of ERBB2 and breast cancer risk: a meta-analysis of 26 studies involving 35,088 subjects.
    Wang H; Liu L; Lang Z; Guo S; Gong H; Guan H; Zhang J; Liu B
    J Surg Oncol; 2013 Nov; 108(6):337-41. PubMed ID: 23900832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer.
    Han X; Diao L; Xu Y; Xue W; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Ann Oncol; 2014 Jun; 25(6):1158-64. PubMed ID: 24608202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features.
    Han W; Kang D; Park IA; Kim SW; Bae JY; Chung KW; Noh DY
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):124-30. PubMed ID: 14734460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites.
    Millikan R; Eaton A; Worley K; Biscocho L; Hodgson E; Huang WY; Geradts J; Iacocca M; Cowan D; Conway K; Dressler L
    Breast Cancer Res Treat; 2003 Jun; 79(3):355-64. PubMed ID: 12846420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
    Wang L; Habuchi T; Takahashi T; Kamoto T; Zuo T; Mitsumori K; Tsuchiya N; Sato K; Ogawa O; Kato T
    Int J Cancer; 2002 Feb; 97(6):787-90. PubMed ID: 11857355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis.
    Tao W; Wang C; Han R; Jiang H
    Breast Cancer Res Treat; 2009 Mar; 114(2):371-6. PubMed ID: 18438707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of HER2 Ile655Val and cyclin D1 (CCND1) G870A are not associated with breast cancer risk but polymorphic allele of HER2 is associated with nodal metastases.
    Naidu R; Yip CH; Taib NA
    Neoplasma; 2008; 55(2):87-95. PubMed ID: 18237245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.